Genentech GO30140 Atezolisumab + Bevacizumab for Solid Tumors - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn what effects, good or bad, atezolizumab has on you and your cancer when combined with bevacizumab and to make sure it is safe.
Who Can Participate in the Study?
- Have advanced or metastatic and/or unresectable hepatocellular carcinoma
What is Involved?
If you choose to join this study, you will:
- Receive either atezolizumab or atezolizumab and bevacizumab every 3 weeks through a vein in your arm
-- Continue to receive the study drug as long as your doctor thinks it is safe